Morpholine → HCID 11656925, compound
Reaction equation
Cl[CH2:2][C:3]([NH:5][CH2:6][CH2:7][C:8]([NH:10][C:11]1[CH:12]=[C:13]2[C:18](=[CH:19][CH:20]=1)[N:17]=[CH:16][N:15]=[C:14]2[NH:21][C:22]1[CH:27]=[CH:26][C:25]([O:28][C:29]2[CH:30]=[N:31][C:32]([CH3:35])=[CH:33][CH:34]=2)=[C:24]([CH3:36])[CH:23]=1)=[O:9])=[O:4].[NH:37]1[CH2:42][CH2:41][O:40][CH2:39][CH2:38]1>>[CH3:36][C:24]1[CH:23]=[C:22]([NH:21][C:14]2[C:13]3[C:18](=[CH:19][CH:20]=[C:11]([NH:10][C:8](=[O:9])[CH2:7][CH2:6][NH:5][C:3](=[O:4])[CH2:2][N:37]4[CH2:42][CH2:41][O:40][CH2:39][CH2:38]4)[CH:12]=3)[N:17]=[CH:16][N:15]=2)[CH:27]=[CH:26][C:25]=1[O:28][C:29]1[CH:30]=[N:31][C:32]([CH3:35])=[CH:33][CH:34]=1Participants
3
Procedure
The procedure of Example 62 was repeated except for using 0.09 g of the compound obtained in Example 67 and 0.05 ml of morpholine instead of the compound obtained in Example 61 to obtain the title compound (0.08 g, 81%).
Sources & evidence
- ORD record
- ord-f076ac4116514100b85d6fbb615d3e5d
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003658B2
Reaction notes
Loading…